Patents by Inventor Szczepan MOGILSKI

Szczepan MOGILSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their use in the treatment of neurological diseases
    Patent number: 12139458
    Abstract: The first object of the invention is the compound of general formula (I) or pharmaceutically acceptable salts thereof. A second object of the invention is the use of compounds described by general formula (I) as active ingredient in pharmaceutical compositions for the treatment of epileptic seizures or neuropathic pain or migraine.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: November 12, 2024
    Assignees: Uniwersytet Jagiellonski, Warszawski Uniwersytet Medyczny
    Inventors: Krzysztof Kaminski, Michal Abram, Anna Rapacz, Szczepan Mogilski, Gniewomir Latacz, Bartlomiej Szulczyk
  • WATER-SOLUBLE, MODIFIED AMINO ACID DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISEASES, AND SELECTED PSYCHIATRIC DISORDERS
    Publication number: 20230192608
    Abstract: Water-soluble analogs of compounds intended for the treatment of neurological diseases, epilepsy, neuropathic pain and migraine, and psychiatric disorders, including anxiety and depression, especially suitable for the preparation of oral or parenteral drug forms, are disclosed.
    Type: Application
    Filed: April 16, 2021
    Publication date: June 22, 2023
    Inventors: Krzysztof KAMINSKI, Michal ABRAM, Marcin JAKUBIEC, Anna RAPACZ, Szczepan MOGILSKI, Gniewomir LATACZ, Marta STRUGA
  • MODIFIED AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND SELECTED PSYCHIATRIC DISORDERS
    Publication number: 20220153694
    Abstract: 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives with R-configuration at the stereogenic center are disclosed, showing broad-spectrum protective activity in animal models of epileptic seizures, pain, depression and anxiety that are simultaneously devoid of undesirable sedative effects. Additionally, the disclosed derivatives have neuroprotective effects in the in vitro and in vivo studies.
    Type: Application
    Filed: April 16, 2020
    Publication date: May 19, 2022
    Inventors: Krzysztof KAMINSKI, Michal ABRAM, Marcin JAKUBIEC, Anna RAPACZ, Szczepan MOGILSKI, Gniewomir LATACZ, Marta STRUGA
  • (2,5-DIOXOPYRROLIDIN-1-YL)(PHENYL)-ACETAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
    Publication number: 20220073461
    Abstract: The first object of the invention is the compound of general formula (I) or pharmaceutically acceptable salts thereof. A second object of the invention is the use of compounds described by general formula (I) as active ingredient in pharmaceutical compositions for the treatment of epileptic seizures or neuropathic pain or migraine.
    Type: Application
    Filed: January 7, 2020
    Publication date: March 10, 2022
    Inventors: Krzysztof KAMINSKI, Michal ABRAM, Anna RAPACZ, Szczepan MOGILSKI, Gniewomir LATACZ, Bartlomiej SZULCZYK